Browsing by Author "García Illescas, David"
Now showing items 1-5 of 5
-
Advances in immunotherapy for cervical cancer
Grau-Bejar, Juan Francisco; Garcia-Duran, Carmen; García Illescas, David; Mirallas Viñas, Oriol; Oaknin Benzaquen, Ana Mazaltob (SAGE Publications, 2023-03-28) -
Advances in the systemic treatment of therapeutic approaches in biliary tract cancer
Mirallas Viñas, Oriol; López-Valbuena, D.; García Illescas, David; Verdaguer Mata, Helena; Tabernero Caturla, Josep; Macarulla Mercadé, Teresa; Fabregat Franco, Carles (Elsevier, 2022-06) -
Overview of Checkpoint Inhibitors Mechanism of Action: Role of Immune-Related Adverse Events and Their Treatment on Progression of Underlying Cancer
Iranzo Gómez, Patricia; Callejo Perez, Ana; Assaf Pastrana, Juan David; Molina, Gaspar; Lopez, Daniel Esteban; García Illescas, David; Pardo Aranda, Nuria; Navarro Mendivil, Alejandro; Martínez Marti, Alexandre; Cedres Perez, Susana; Amat, Ramon; Felip Font, Enriqueta; Carbonell, Caterina; Frigola Rissech, Joan (Frontiers Media, 2022-05-30) -
Ripretinib in gastrointestinal stromal tumor: the long-awaited step forward
Lostes Bardaji, M Julia; García Illescas, David; Valverde Morales, Claudia Maria; Serrano Garcia, César (SAGE Publications, 2021-01) -
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
Dettorre, Gino M; Dolly, Saoirse; Loizidou, Angela; Chester, John; Jackson, Amanda; Mukherjee, Uma; Aguilar Company, Juan; Mirallas Viñas, Oriol; García Illescas, David; Ruiz Camps, Isabel; Tabernero Caturla, Josep; Saoudi Gonzalez, Nadia (BMJ Publishing Group, 2021-03-22)